Enanta Pharmaceuticals, Inc. · NASDAQ:ENTA
Millennium Management LLC reported a 6.50% stake in Enanta Pharmaceuticals, Inc. (Schedule 13G)
Event Jan 14, 2025 · Filed Jan 22, 2025
Millennium Management LLC reported a 6.50% stake in Enanta Pharmaceuticals, Inc., 1,382,273 shares, as a passive investor on Jan 14, 2025. Filed Jan 22, 2025 (Schedule 13G).
- Stake
- 6.50%
- Shares
- 1,382,273
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 5.30% | 1,125,777 |
| Millennium Management LLC | 6.50% | 1,382,273 |
| Millennium Group Management LLC | 6.50% | 1,382,273 |
| Israel A. Englander | 6.50% | 1,382,273 |
Source
Related
- Enanta Pharmaceuticals, Inc.
- Millennium Management LLC
- Enanta Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Jan 20, 2026
- Schedule 13G/A · Millennium Management LLC · Nov 13, 2025
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 14, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Form 4 · Rottinghaus Scott T. · Aug 10, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · Deep Track Capital, LP · Feb 13, 2026